CDK7
CDK7 (cyclin-dependent kinase 7, also known as CAK1, CAK, CDKN7, MO15 and STK1) is a serine/threonine kinase that links cell cycle control with RNA polymerase II-mediated transcription. It is the catalytic subunit of the CDK-activating kinase (CAK) complex. Browse Assay Genie's current range of CDK7 research reagents below, or read on for the biology behind the target.
CDK7 is a serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated transcription. Like other cyclin-dependent kinases, it is activated by binding to cyclin-H (CCNH) and the CDK-activating kinase assembly factor MAT1, forming a trimeric complex that functions as the CDK-activating kinase (CAK). As catalytic subunit of CAK, CDK7 acts as a master regulator of CDK activity by catalysing the activating threonine phosphorylation of CDKs, including CDK1, CDK2, CDK4 and CDK6, and so plays a key role in cell cycle progression.
CDK7 also has a transcriptional role. CAK complexed to the core-TFIIH basal transcription factor phosphorylates the C-terminal domain (CTD) of POLR2A, including at Ser-5 when POLR2A is in complex with DNA. This promotes dissociation from DNA, promoter escape and elongation of transcripts. Other reported substrates include SPT5/SUPT5H, SF1/NR5A1, p53/TP53 and CDK11B/CDK11. Unlike many CDKs, its expression and activity are constant throughout the cell cycle. NCBI Gene describes it as a direct link between the regulation of transcription and the cell cycle, and TFIIH is involved in both transcription initiation and DNA repair.
After DNA damage, CDK7 triggers p53/TP53 activation by phosphorylation but is in turn inactivated by p53/TP53. This feedback loop may lead to arrest of the cell cycle and transcription, helping cell recovery, or to apoptosis. The CDK7 protein belongs to the CMGC Ser/Thr protein kinase family, CDC2/CDKX subfamily, and is similar to yeast cdc28 and cdc2. The name MO15 reflects its original identification as the Xenopus cdk-activating kinase homologue. The mouse and rat orthologues are both named Cdk7.
CDK7 activates CDK1, CDK2, CDK4 and CDK6 by activating phosphorylation, making it central to studies of cell cycle progression.
As part of TFIIH, CDK7 phosphorylates the POLR2A CTD, enabling promoter escape and transcript elongation by RNA polymerase II.
CDK7 phosphorylates p53/TP53 after DNA damage and is inactivated by it in turn, a feedback loop linked to arrest or apoptosis.
The CDK7, cyclin H and MAT1 trimer forms the CAK complex, a model for studying cyclin-dependent kinase assembly and activation.
CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex, which phosphorylates and activates CDKs such as CDK1, CDK2, CDK4 and CDK6. Within TFIIH it also phosphorylates the POLR2A C-terminal domain, supporting transcription initiation by RNA polymerase II.
HGNC names the gene cyclin dependent kinase 7. Aliases and previous symbols include CAK1, CAK, CDKN7, MO15 and STK1. Earlier names referred to the Xenopus MO15 cdk-activating kinase homologue. It belongs to the CDK activating kinase complex gene group.
Yes. Mouse and rat both have an orthologue named Cdk7. The CDK family is highly similar to yeast cdc28 and cdc2 gene products, which regulate cell cycle progression. Check the datasheet of any product for its validated reactivity.
Other cyclin-dependent kinases, CAK substrates and CDK inhibitors involved in cell cycle and transcription control.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P50613; product specifications from Assay Genie datasheets.